Menu
Search
|

Menu

Close
X

Presbia PLC LENS.OQ (NASDAQ Stock Exchange Capital Market)

3.06 USD
+0.02 (+0.66%)
As of Feb 23
chart
Previous Close 3.04
Open 3.23
Volume 926
3m Avg Volume 17,190
Today’s High 3.23
Today’s Low 3.06
52 Week High 7.00
52 Week Low 1.86
Shares Outstanding (mil) 17.12
Market Capitalization (mil) 87.92
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.50 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY17
0
FY16
0
FY15
0
EPS (USD)
FY17
-0.869
FY16
-0.893
FY15
-1.407
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.90
Price to Sales (TTM)
vs sector
6,763.27
5.77
Price to Book (MRQ)
vs sector
8.13
5.41
Price to Cash Flow (TTM)
vs sector
--
23.42
Total Debt to Equity (MRQ)
vs sector
8.95
16.52
LT Debt to Equity (MRQ)
vs sector
4.13
12.22
Return on Investment (TTM)
vs sector
-128.77
14.43
Return on Equity (TTM)
vs sector
-131.71
16.13

EXECUTIVE LEADERSHIP

Mark Yung
Executive Chairman of the Board, Since 2017
Salary: --
Bonus: --
Todd Cooper
President, Chief Executive Officer, Director, Since 2015
Salary: --
Bonus: --
Casey Lind
Chief Operating Officer, Since 2018
Salary: --
Bonus: --
Richard Fogarty
Chief Accounting Officer, Vice President - Finance, Secretary, Since 2018
Salary: --
Bonus: --
John Strobel
Vice President of Sales, Since 2015
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

Ste 7
Sandyford Office Centre, 17 Corr
DUBLIN     00000

Phone: +3531.5511487
Site: presbia.com/

Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company's segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company's lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient's eye to improve that patient's ability to see objects at close distances. The microlens is a disc shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia and a central zone that is designed to improve distance vision. The Company's solution is a standalone solution for plano presbyopes, or those individuals suffering from presbyopia but do not have any other visual disorders.

SPONSORED STORIES